These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 15191451)
1. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Radesic B; Sharma A Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451 [TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting. Macnab JL; Lowles IE J Obstet Gynaecol; 2002 Jul; 22(4):402-5. PubMed ID: 12521465 [TBL] [Abstract][Full Text] [Related]
3. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195 [TBL] [Abstract][Full Text] [Related]
4. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey. Römer T; Linsberger D Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641 [TBL] [Abstract][Full Text] [Related]
5. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland. Backman T; Huhtala S; Tuominen J; Luoto R; Erkkola R; Blom T; Rauramo I; Koskenvuo M Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():23-6. PubMed ID: 11336430 [TBL] [Abstract][Full Text] [Related]
6. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
7. The Femilis LNG-IUS: contraceptive performance-an interim analysis. Wildemeersch D; Janssens D; Andrade A Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705 [TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Daud S; Ewies AA Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537 [TBL] [Abstract][Full Text] [Related]
9. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Rose S; Chaudhari A; Peterson CM Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984 [TBL] [Abstract][Full Text] [Related]
10. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Rönnerdag M; Odlind V Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065 [TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
12. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Jensen JT; Nelson AL; Costales AC Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662 [TBL] [Abstract][Full Text] [Related]
13. Selection and performance of the levonorgestrel-releasing intrauterine system. Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643 [TBL] [Abstract][Full Text] [Related]
14. Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders. Rimmer E; Jamieson MA; James P Haemophilia; 2013 Nov; 19(6):933-8. PubMed ID: 23711358 [TBL] [Abstract][Full Text] [Related]
15. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D; Janssens D; Vrijens M; Weyers S Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138 [TBL] [Abstract][Full Text] [Related]
16. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system. de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176 [TBL] [Abstract][Full Text] [Related]
17. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction. Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I; Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346 [TBL] [Abstract][Full Text] [Related]
18. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Lukes AS; Reardon B; Arepally G Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system. Gemzell-Danielsson K; Inki P; Heikinheimo O Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367 [TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system. Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]